PTPRC and neoplasm: To validate nanostring RNA transcript results in the apoE targeted group, we performed immunohistochemistry staining of the immune cell marker CD45 (lymphocyte common antigen) and CD3 (T cell marker) on the same tumor samples that we used for nanostring analysis.